Acceleration process - Regulinked.com

EDE has issued Pharmacovigilance Practice Guideline for Medical Products

According to Resolution No. (27) of 2026, published by the Emirates Drug

SFDA has issued Regulatory Guide for SFDA Services in Duty- and Tax-Suspended Zones

SFDA has issued a new regulatory guide clarifying the services and requirements

SFDA published six guidelines regarding classification of violations and associated penalties

SFDA has published six guidelines regarding classification of violations and associated penalties

SFDA Issues “Guidelines for Chemical and Pharmaceutical Quality Documentation of Small Molecules Investigational Products in Clinical Trials” (Version 1.0)

Saudi Food and Drug Authority (SFDA) has issued Version 1.0 of new

SFDA Issues Updated Guidance on “Combination Products Classification and Registration” (Version 2.0)

SFDA has issued Version 2.0 of the “Guidance for Combination Products Classification

SFDA – “Products Classification Guidance” V 9.0

SFDA has issued Version 9.0 of the “Products Classification Guidance”, introducing updated

SFDA- “Clinical Considerations for Vaccines” V 2.0

SFDA issued the updated “Clinical Considerations for Vaccines” guideline – Version 2.0

SFDA- “Verification & Abridged Pathways” Guideline updates

SFDA issues updated “Verification & Abridged Pathways” Guideline (Version 3.0 — Issued

ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.

Category: Acceleration process